A detailed history of Advisor Group Holdings, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 8,836 shares of ALKS stock, worth $261,103. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,836
Previous 7,438 18.8%
Holding current value
$261,103
Previous $179,000 37.99%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.01 - $28.55 $32,167 - $39,912
1,398 Added 18.8%
8,836 $247,000
Q2 2024

Aug 13, 2024

SELL
$23.21 - $27.24 $55,843 - $65,539
-2,406 Reduced 24.44%
7,438 $179,000
Q1 2024

May 10, 2024

SELL
$26.4 - $32.56 $42,504 - $52,421
-1,610 Reduced 14.06%
9,844 $266,000
Q4 2023

Feb 12, 2024

SELL
$23.37 - $28.68 $49,263 - $60,457
-2,108 Reduced 15.54%
11,454 $317,000
Q3 2023

Nov 13, 2023

BUY
$27.17 - $31.97 $34,044 - $40,058
1,253 Added 10.18%
13,562 $379,000
Q2 2023

Aug 21, 2023

SELL
$28.34 - $33.63 $6,008 - $7,129
-212 Reduced 1.69%
12,309 $385,000
Q2 2023

Aug 10, 2023

SELL
$28.34 - $33.63 $126,424 - $150,023
-4,461 Reduced 26.27%
12,521 $391,000
Q1 2023

May 12, 2023

BUY
$25.31 - $29.02 $32,320 - $37,058
1,277 Added 8.13%
16,982 $478,000
Q4 2022

Feb 10, 2023

BUY
$21.94 - $26.24 $2,698 - $3,227
123 Added 0.79%
15,705 $410,000
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $25,630 - $37,128
1,165 Added 8.08%
15,582 $348,000
Q2 2022

Aug 10, 2022

SELL
$26.4 - $30.54 $32,709 - $37,839
-1,239 Reduced 7.91%
14,417 $429,000
Q1 2022

May 04, 2022

BUY
$23.07 - $27.99 $233,929 - $283,818
10,140 Added 183.83%
15,656 $412,000
Q3 2021

Nov 05, 2021

BUY
$23.37 - $32.13 $30,264 - $41,608
1,295 Added 30.68%
5,516 $171,000
Q2 2021

Aug 02, 2021

SELL
$18.78 - $25.15 $6,666 - $8,928
-355 Reduced 7.76%
4,221 $103,000
Q1 2021

May 13, 2021

BUY
$18.21 - $23.2 $8,941 - $11,391
491 Added 12.02%
4,576 $85,000
Q4 2020

Feb 10, 2021

BUY
$15.39 - $22.1 $169 - $243
11 Added 0.27%
4,085 $82,000
Q3 2020

Nov 12, 2020

BUY
$16.16 - $20.66 $22,042 - $28,180
1,364 Added 50.33%
4,074 $67,000
Q2 2020

Aug 14, 2020

SELL
$13.31 - $19.41 $1,996 - $2,911
-150 Reduced 5.24%
2,710 $53,000
Q1 2020

May 18, 2020

BUY
$13.06 - $21.24 $37,351 - $60,746
2,860 New
2,860 $41,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.85B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.